Jingfang Granules for prevention of alcohol-induced hangover: a randomized, double-blind, crossover trial in healthy volunteers
Frontiers in Pharmacology · 13.05.2026 · 17
DOI: 10.3389/fphar.2026.1717099 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Frontiers in Pharmacology, online erschienen am 13.05.2026. Verfasst von Feng Wu und 8 weiteren Autor:innen. Beteiligte Einrichtung: National Institute for Drug Clinical Trial, Beijing Tongren Hospital, Capital Medical University, Beijing, China. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Jingfang Granules (JFG), a classical traditional Chinese medicine formula comprising 11 botanical drugs, have traditionally been prescribed to dispel cold and eliminate dampness. This study aimed to clinically evaluate the efficacy and safety of JFG in accelerating alcohol clearance and mitigating hangover symptoms.
Methods
A randomized, double-blind, two-period crossover trial enrolled 48 healthy adults. Participants received JFG (6 sachets × 15 g) or placebo 30 min before consuming 100 mL of 56% ABV baijiu within 10 min. Primary endpoints were plasma alcohol concentrations measured up to 24 h post-consumption. Secondary endpoints included plasma alcohol AUC 0–24 h , plasma alcohol dehydrogenase (ADH) and acetaldehyde dehydrogenase (ALDH) activities, hangover severity assessed using the Acute Hangover Scale (AHS), urine output, and safety.
Results
JFG significantly reduced plasma alcohol concentrations from 30 min to 8 h after consumption (P < 0.005) and decreased plasma alcohol AUC 0–24 h (P < 0.001) compared with placebo. AHS scores were numerically lower following JFG treatment; however, the differences were not statistically significant (P > 0.05). JFG administration was associated with greater urine volume (P < 0.001) and fewer urination episodes (P = 0.032). No severe or serious adverse events were reported.
Discussion
JFG significantly reduced plasma alcohol levels for up to 8 h after consumption and showed a trend toward lower hangover symptom scores; however, the mechanism remains unknown. Clinical Trial Registration https://www.chictr.org.cn/ , identifier ChiCTR2400084155.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- National Institute for Drug Clinical Trial, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
Zitieren
APA
Wu, F., Dai, Y., Ni, S., Zhang, J., Hu, X., Han, Y., Jiao, Y., Lu, H., & Lu, L. (2026). Jingfang Granules for prevention of alcohol-induced hangover: a randomized, double-blind, crossover trial in healthy volunteers. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1717099
Vancouver
Wu F, Dai Y, Ni S, Zhang J, Hu X, Han Y, et al. Jingfang Granules for prevention of alcohol-induced hangover: a randomized, double-blind, crossover trial in healthy volunteers. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1717099
BibTeX
@article{Wu2026,
author = {Wu, Feng and Dai, Yuyang and Ni, Siyang and Zhang, Jing and Hu, Xiaojun and Han, Ying and Jiao, Ying and Lu, Huan and Lu, Laichun},
title = {Jingfang Granules for prevention of alcohol-induced hangover: a randomized, double-blind, crossover trial in healthy volunteers},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1717099}
}
EUVIMED